Global levels of histone modifications predict prognosis in different cancers

American Journal of Pathology

Volumn 174, Issue 5, 2009, Pages 1619-1628

  Seligson, David B ^a   Horvath, Steve ^a,b   McBrian, Matthew A ^b   Mah, Vei ^a   Yu, Hong ^a   Tze, Sheila ^a   Wang, Qun ^a   Chia, David ^a   Goodglick, Lee ^a   Kurdistani, Siavash K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; KI 67 ANTIGEN; LYSINE; PROTEIN P53; REPETITIVE DNA; HISTONE;

ACETYLATION; ADENOCARCINOMA; ADULT; AGED; ARTICLE; CELL LEVEL; CHROMATIN IMMUNOPRECIPITATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN METHYLATION; PROTEIN MODIFICATION; CELL PROLIFERATION; COHORT ANALYSIS; ENZYME IMMUNOASSAY; GENETICS; KIDNEY TUMOR; LUNG TUMOR; METABOLISM; METHYLATION; MIDDLE AGED; NUCLEOTIDE REPEAT; PROMOTER REGION; PROSTATE TUMOR; PROTEIN PROCESSING; TISSUE MICROARRAY; WESTERN BLOTTING;

ACETYLATION; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COHORT STUDIES; FEMALE; HISTONES; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; METHYLATION; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPETITIVE SEQUENCES, NUCLEIC ACID; TISSUE ARRAY ANALYSIS;

EID: 65649142216     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080874     Document Type: Article

References (33)

1. Baylin SB, Ohm JE: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006, 6:107-116
2. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat Rev Cancer 2004, 4:143-153 (Pubitemid 38198742)
3. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007, 128:683-692 (Pubitemid 46273572)
4. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998, 391:597-601 (Pubitemid 28157603)
5. Hake SB, Xiao A, Allis CD: Linking the epigenetic 'language' of covalent histone modifications to cancer. Br J Cancer 2004, 90:761-769
6. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005, 37:391-400 (Pubitemid 40490489)
7. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK: Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005, 435:1262-1266 (Pubitemid 40943093)
8. Ludwig JA, Weinstein JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005, 5:845-856 (Pubitemid 41746029)
9. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537
10. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511 (Pubitemid 30082188)
11. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature 2000, 406:747-752
12. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874 (Pubitemid 32878711)
13. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003, 100:10393-10398 (Pubitemid 37071889)
14. Esteller M: DNA methylation and cancer therapy: new developments and expectations. Curr Opin Oncol 2005, 17:55-60 (Pubitemid 40179913)
15. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000, 343:1350-1354
16. Seligson DB: The tissue micro-array as a translational research tool for biomarker profiling and validation. Biomarkers 2005, 10(Suppl 1):S77-S82
17. Suka N, Suka Y, Carmen AA, Wu J, Grunstein M: Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin. Mol Cell 2001, 8:473-479 (Pubitemid 32831564)
18. Wang G, Balamotis MA, Stevens JL, Yamaguchi Y, Handa H, Berk AJ: Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Mol Cell 2005, 17:683-694 (Pubitemid 40320918)
19. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847 (Pubitemid 28331029)
20. Liu X, Minin V, Huang Y, Seligson DB, Horvath S: Statistical methods for analyzing tissue microarray data. J Biopharm Stat 2004, 14:671-685 (Pubitemid 39296092)
21. Maddau C, Confortini M, Bisanzi S, Janni A, Montinaro F, Paci E, Pontenani G, Rulli P, Salani A, Zappa M, Benvenuti A, Carozzi FM: Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detection with imprint cytology. Am J Clin Pathol 2006, 125:425-431 (Pubitemid 43327713)
22. Shvarts O, Seligson D, Lam J, Shi T, Horvath S, Figlin R, Belldegrun A, Pantuck AJ: p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma. J Urol 2005, 173:725-728 (Pubitemid 40239328)
23. Visapää H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A: Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 2003, 61:845-850 (Pubitemid 36384994)
24. Barlési F, Giaccone G, Gallegos-Ruiz MI, Loundou A, Span SW, Lefesvre P, Kruyt FA, Rodriguez JA: Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol 2007, 25:4358-4364 (Pubitemid 350013840)
25. Wei Y, Xia W, Zhang Z, Liu J, Wang H, Adsay NV, Albarracin C, Yu D, Abbruzzese JL, Mills GB, Bast Jr RC, Hortobagyi GN, Hung MC: Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 2008, 47:701-706
26. Li WH, Gu Z, Wang H, Nekrutenko A: Evolutionary analyses of the human genome. Nature 2001, 409:847-849 (Pubitemid 32165341)
27. Esteller M: Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2006, 94:179-183 (Pubitemid 43151531)
28. Kurdistani SK: Histone modifications as markers of cancer prognosis: a cellular view. Br J Cancer 2007, 97:1-5 (Pubitemid 47012099)
29. Robyr D, Suka Y, Xenarios I, Kurdistani SK, Wang A, Suka N, Grunstein M: Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases. Cell 2002, 109:437-446 (Pubitemid 34564471)
30. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, Kurdistani SK: Epigenetic reprogramming by adenovirus e1a. Science 2008, 321:1086-1088
31. Horwitz GA, Zhang K, McBrian MA, Grunstein M, Kurdistani SK, Berk AJ: Adenovirus small e1a alters global patterns of histone modification. Science 2008, 321:1084-1085
32. Egger G, Liang G, Aparicio A, Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429:457-463 (Pubitemid 38715140)
33. Minucci S, Pelicci PG: Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006, 6:38-51 (Pubitemid 43054973)